“…After the multivariate analysis, four variables including tumor location (low), high level of TgAb (>1,150 IU/ml), the irregular margin of CLN, and micro-calcification in the CLN were independent risk factors in promoting CLM in patients with HT. However, in PTC patients with HT, we did not successfully validate the clinical factors which were previously confirmed significantly associated with the CLNM like male gender, large tumor size, age <55 years, or multifocality (27,32,33). Possible reasons were the relatively small sample size, the different including criteria, and study setting compared with our previous work on predicting the cervical lymph node metastasis in classic PTC patients (34).…”